93 related articles for article (PubMed ID: 10340385)
1. P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
Agapova LS; Ivanov AV; Sablina AA; Kopnin PB; Sokova OI; Chumakov PM; Kopnin BP
Oncogene; 1999 May; 18(20):3135-42. PubMed ID: 10340385
[TBL] [Abstract][Full Text] [Related]
2. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
3. [The protective role of p53 in Ras-induced transformation of REF52 cells].
Kopnin PB; Ivanov AV; Il'inskaia GV; Sablina AA; Kopnin BP; Chumakov PM
Mol Biol (Mosk); 2003; 37(3):458-71. PubMed ID: 12815953
[TBL] [Abstract][Full Text] [Related]
4. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53.
Olivier M; Bautista S; Vallès H; Theillet C
Mol Carcinog; 1998 Sep; 23(1):1-12. PubMed ID: 9766432
[TBL] [Abstract][Full Text] [Related]
5. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
7. [Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53].
Agapova LS; Turovets NA; Ivanov AV; Il'inskaia GV; Chumakov PM
Genetika; 1996 Aug; 32(8):1080-7. PubMed ID: 8964480
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inactivating various components of the signal pathways of the tumor suppressor p53 on genomic stability].
Turovets NA; Chumakov PM; Kopnin BP
Genetika; 1999 Dec; 35(12):1651-8. PubMed ID: 10687094
[TBL] [Abstract][Full Text] [Related]
9. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
Schmid G; Kramer MP; Wesierska-Gadek J
J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
[TBL] [Abstract][Full Text] [Related]
10. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
11. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
12. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
14. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
[TBL] [Abstract][Full Text] [Related]
15. [Opposite effect of p53 on nucleotide metabolizing enzyme activity in Rat1 cells and their sublines, transformed by N-RAS or v-mos oncogenes].
Khramtsova SN; Osovskaia VS; Semeniak OIu; Potapova GI; Chumakov PM; Kopnin BP
Biokhimiia; 1995 Nov; 60(11):1881-8. PubMed ID: 8590759
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
18. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
20. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]